Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kalaria, VG; Ling, FS
   Late stent thrombosis without antecedent brachytherapy: Confirmation and treatment with rheolytic thrombectomy
   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
   
   V.G. Kalaria e F.S. Ling, "Late stent thrombosis without antecedent brachytherapy: Confirmation and treatment with rheolytic thrombectomy", CATHET C IN, 53(2), 2001, pp. 243-247
2. Zurbrugg, HR; Musci, M; Sanger, S; Gutersohn, A; Mulling, C; Wellnhofer, E; Schaffner, T; Hetzer, R
   Prevention of venous graft sclerosis with clopidogrel and aspirin combinedwith a mesh tubing in a dog model of arteriovenous bypass grafting
   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
   
   H.R. Zurbrugg et al., "Prevention of venous graft sclerosis with clopidogrel and aspirin combinedwith a mesh tubing in a dog model of arteriovenous bypass grafting", EUR J VAS E, 22(4), 2001, pp. 337-341
3. Santillan, MKO; Herring, J; Hoppensteadt, DA; Jeske, W; Herbert, JM; Fareed, J
   The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   M.K.O. Santillan et al., "The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys", CL APPL T-H, 7(1), 2001, pp. 10-15
4. Reinisch, CM; Dunzendorfer, S; Pechlaner, C; Ricevuti, G; Wiedermann, CJ
   The inhibition of oxygen radical release from human neutrophil by resting platelets is reversed by administration of acetylsalicylic acid or clopidogrel
   FREE RADICAL RESEARCH
   
   C.M. Reinisch et al., "The inhibition of oxygen radical release from human neutrophil by resting platelets is reversed by administration of acetylsalicylic acid or clopidogrel", FREE RAD RE, 34(5), 2001, pp. 461-466
5. El-Beyrouty, C; Spinler, SA
   Cilostazol for prevention of thrombosis and restenosis after intracoronarystenting
   ANNALS OF PHARMACOTHERAPY
   
   C. El-Beyrouty e S.A. Spinler, "Cilostazol for prevention of thrombosis and restenosis after intracoronarystenting", ANN PHARMAC, 35(9), 2001, pp. 1108-1113
6. Majid, A; Delanty, N; Kantor, J
   Antiplatelet agents for secondary prevention of ischemic stroke
   ANNALS OF PHARMACOTHERAPY
   
   A. Majid et al., "Antiplatelet agents for secondary prevention of ischemic stroke", ANN PHARMAC, 35(10), 2001, pp. 1241-1247
7. Bogousslavsky, J
   Benefit of ADP receptor antagonists in atherothrombotic patients: New evidence
   CEREBROVASCULAR DISEASES
   
   J. Bogousslavsky, "Benefit of ADP receptor antagonists in atherothrombotic patients: New evidence", CEREB DIS, 11, 2001, pp. 5-10
8. Yadav, JS
   Management practices in carotid stenting
   CEREBROVASCULAR DISEASES
   
   J.S. Yadav, "Management practices in carotid stenting", CEREB DIS, 11, 2001, pp. 18-22
9. Easton, JD
   Future perspectives for optimizing oral antiplatelet therapy
   CEREBROVASCULAR DISEASES
   
   J.D. Easton, "Future perspectives for optimizing oral antiplatelet therapy", CEREB DIS, 11, 2001, pp. 23-28
10. Bornstein, NM
    Antiplatelet drugs: How to select them and possibilities of combined treatment
    CEREBROVASCULAR DISEASES
    
    N.M. Bornstein, "Antiplatelet drugs: How to select them and possibilities of combined treatment", CEREB DIS, 11, 2001, pp. 96-99
11. Scarborough, RM; Laibelman, AM; Clizbe, LA; Fretto, LJ; Conley, PB; Reynolds, EE; Sedlock, DM; Jantzen, HM
    Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12))
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    R.M. Scarborough et al., "Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12))", BIOORG MED, 11(14), 2001, pp. 1805-1808
12. Maayani, S; Tagliente, TM; Schwarz, T; Craddock-Royal, B; Alcala, C; Marrero, G; Martinez, R
    Deaggregation is an integral component of the response of platelets to ADPin vitro: kinetic studies of literature and original data
    PLATELETS
    
    S. Maayani et al., "Deaggregation is an integral component of the response of platelets to ADPin vitro: kinetic studies of literature and original data", PLATELETS, 12(5), 2001, pp. 279-291
13. Maayani, S; Tagliente, TM; Schwarz, T; Martinelli, G; Martinez, R; Shore-Lesserson, L
    The balance of concurrent aggregation and deaggregation processes in platelets is linked to differential occupancy of ADP receptor subtypes
    PLATELETS
    
    S. Maayani et al., "The balance of concurrent aggregation and deaggregation processes in platelets is linked to differential occupancy of ADP receptor subtypes", PLATELETS, 12(2), 2001, pp. 83-93
14. Maayani, S; Schwarz, T; Martinez, R; Tagliente, TM
    Activation of G(i)-coupled receptors releases a tonic state of inhibited platelet aggregation
    PLATELETS
    
    S. Maayani et al., "Activation of G(i)-coupled receptors releases a tonic state of inhibited platelet aggregation", PLATELETS, 12(2), 2001, pp. 94-98
15. Ziegler, V; Schlesinger, S; Griewing, B; Samland, O
    Bleeding complications in combined treatment with clopidrogel and low-doseheparin in stroke patients
    PERFUSION
    
    V. Ziegler et al., "Bleeding complications in combined treatment with clopidrogel and low-doseheparin in stroke patients", PERFUSION, 14(7), 2001, pp. 259-262
16. Sugio, Y; Okamura, T; Shimoda, K; Matsumoto, M; Yagi, H; Ishizashi, H; Niho, Y; Inaba, S; Fujimura, Y
    Ticlopidine-associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    Y. Sugio et al., "Ticlopidine-associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity", INT J HEMAT, 74(3), 2001, pp. 347-351
17. Calvin, JE; Klein, LW
    The use of antiplatelet agents in acute cardiac care
    CRITICAL CARE CLINICS
    
    J.E. Calvin e L.W. Klein, "The use of antiplatelet agents in acute cardiac care", CRIT CARE C, 17(2), 2001, pp. 365
18. Schuhlen, H; Kastrati, A; Pache, J; Dirschinger, J; Schomig, A
    Incidence of thrombotic occlusion and major adverse cardiac events betweentwo and four weeks after coronary stent placement: Analysis of 5,678 patients with a four-week ticlopidine regimen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    H. Schuhlen et al., "Incidence of thrombotic occlusion and major adverse cardiac events betweentwo and four weeks after coronary stent placement: Analysis of 5,678 patients with a four-week ticlopidine regimen", J AM COL C, 37(8), 2001, pp. 2066-2073
19. Scrutinio, D; Cimminiello, C; Marubini, E; Pitzalis, MV; Di Biase, M; Rizzon, P
    Ticlopidine versus aspirin after myocardial infarction (STAMI) trial
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    D. Scrutinio et al., "Ticlopidine versus aspirin after myocardial infarction (STAMI) trial", J AM COL C, 37(5), 2001, pp. 1259-1265
20. Cattaneo, M; Gachet, C
    The platelet ADP receptors
    HAEMATOLOGICA
    
    M. Cattaneo e C. Gachet, "The platelet ADP receptors", HAEMATOLOG, 86(4), 2001, pp. 346-348
21. Poele, JAMT; Van Kleef, EM; Van der Wal, AF; Dewit, LGH; Stewart, FA
    Radiation-induced glomerular thrombus formation and nephropathy are not prevented by the ADP receptor antagonist clopidogrel
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    J.A.M.T. Poele et al., "Radiation-induced glomerular thrombus formation and nephropathy are not prevented by the ADP receptor antagonist clopidogrel", INT J RAD O, 50(5), 2001, pp. 1332-1338
22. Lowe, HC; Kumar, RK; Chesterman, CN; Fahmy, RG; Khachigian, LM
    Coronary stent thrombosis: Insights from the porcine coronary stent model
    THROMBOSIS AND HAEMOSTASIS
    
    H.C. Lowe et al., "Coronary stent thrombosis: Insights from the porcine coronary stent model", THROMB HAEM, 86(3), 2001, pp. 937-938
23. Eckly, A; Gendrault, JL; Hechler, B; Cazenave, JP; Gachet, C
    Differential involvement of the P2Y(1) and P2Y(T) receptors in the morphological changes of platelet aggregation
    THROMBOSIS AND HAEMOSTASIS
    
    A. Eckly et al., "Differential involvement of the P2Y(1) and P2Y(T) receptors in the morphological changes of platelet aggregation", THROMB HAEM, 85(4), 2001, pp. 694-701
24. Storey, RF; Oldroyd, KG; Wilcox, RG
    Open multicentre study of the P-2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes
    THROMBOSIS AND HAEMOSTASIS
    
    R.F. Storey et al., "Open multicentre study of the P-2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes", THROMB HAEM, 85(3), 2001, pp. 401-407
25. Weber, AA; Braun, M; Hohlfeld, T; Schwippert, B; Tschope, D; Schror, K
    Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    A.A. Weber et al., "Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers", BR J CL PH, 52(3), 2001, pp. 333-336
26. Valentin, V
    Clopidogrel in acute coronary syndromes with non-ST elevation. Clinical implications of CURE trial
    REVISTA ESPANOLA DE CARDIOLOGIA
    
    V. Valentin, "Clopidogrel in acute coronary syndromes with non-ST elevation. Clinical implications of CURE trial", REV ESP CAR, 54(10), 2001, pp. 1127-1134
27. Swanson, N; Hogrefe, K; Lloyd, AS; Gershlick, A
    Current perspectives on British use of adjunctive therapies during coronary interventions
    INTERNATIONAL JOURNAL OF CARDIOLOGY
    
    N. Swanson et al., "Current perspectives on British use of adjunctive therapies during coronary interventions", INT J CARD, 79(2-3), 2001, pp. 119-125
28. Amoroso, G; van Boven, AJ; van Veldhuisen, DJ; Tio, RA; Balje-Volkers, CP; Petronio, AS; van Oeveren, W
    Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients withcoronary artery disease
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    G. Amoroso et al., "Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients withcoronary artery disease", J CARDIO PH, 38(4), 2001, pp. 633-641
29. Thurmann, PA
    Methods and systems to detect adverse drug reactions in hospitals
    DRUG SAFETY
    
    P.A. Thurmann, "Methods and systems to detect adverse drug reactions in hospitals", DRUG SAFETY, 24(13), 2001, pp. 961-968
30. Hollopeter, G; Jantzen, HM; Vincent, D; Li, G; England, L; Ramakrishnan, V; Yang, RB; Nurden, P; Nurden, A; Julius, D; Conley, PB
    Identification of the platelet ADP receptor targeted by antithrombotic drugs
    NATURE
    
    G. Hollopeter et al., "Identification of the platelet ADP receptor targeted by antithrombotic drugs", NATURE, 409(6817), 2001, pp. 202-207
31. Foster, CJ; Prosser, DM; Agans, JM; Zhai, Y; Smith, MD; Lachowicz, JE; Zhang, FL; Gustafson, E; Monsma, FJ; Wiekowski, MT; Abbondanzo, SJ; Cook, DN; Bayne, ML; Lira, SA; Chintala, MS
    Molecular identification and characterization of the platelet ADP receptortargeted by thienopyridine antithrombotic drugs
    JOURNAL OF CLINICAL INVESTIGATION
    
    C.J. Foster et al., "Molecular identification and characterization of the platelet ADP receptortargeted by thienopyridine antithrombotic drugs", J CLIN INV, 107(12), 2001, pp. 1591-1598
32. Baurand, A; Raboisson, P; Freund, M; Leon, C; Cazenave, JP; Bourguignon, JJ; Gachet, C
    Inhibition of platelet function by administration of MRS2179, a P2Y(1) receptor antagonist
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    A. Baurand et al., "Inhibition of platelet function by administration of MRS2179, a P2Y(1) receptor antagonist", EUR J PHARM, 412(3), 2001, pp. 213-221
33. Leon, C; Freund, M; Ravanat, C; Baurand, A; Cazenave, JP; Gachet, C
    Key role of the P2Y(1) receptor in tissue factor-Induced thrombin-dependent acute thromboembolism - Studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist
    CIRCULATION
    
    C. Leon et al., "Key role of the P2Y(1) receptor in tissue factor-Induced thrombin-dependent acute thromboembolism - Studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist", CIRCULATION, 103(5), 2001, pp. 718-723
34. Steinhubl, SR; Ellis, SG; Wolski, K; Lincoff, AM; Topol, EJ
    Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial
    CIRCULATION
    
    S.R. Steinhubl et al., "Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial", CIRCULATION, 103(10), 2001, pp. 1403-1409
35. Reichenberger, F; Wirtz, H; Paschke, R
    Clopidogrel and side effects
    CARDIOLOGY
    
    F. Reichenberger et al., "Clopidogrel and side effects", CARDIOLOGY, 96(1), 2001, pp. 51-52
36. Zhao, L; Bath, P; Heptinstall, S
    Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro
    BRITISH JOURNAL OF PHARMACOLOGY
    
    L. Zhao et al., "Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro", BR J PHARM, 134(2), 2001, pp. 353-358
37. Sugidachi, A; Asai, F; Yoneda, K; Iwamura, R; Ogawa, T; Otsuguro, K; Koike, H
    Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747
    BRITISH JOURNAL OF PHARMACOLOGY
    
    A. Sugidachi et al., "Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747", BR J PHARM, 132(1), 2001, pp. 47-54
38. Savi, P; Labouret, C; Delesque, N; Guette, F; Lupker, J; Herbert, JM
    P2Y(12), a new platelet ADP receptor, target of clopidogrel
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    P. Savi et al., "P2Y(12), a new platelet ADP receptor, target of clopidogrel", BIOC BIOP R, 283(2), 2001, pp. 379-383
39. Spannagl, M; Frey, L
    New antiplatelet drugs
    ANAESTHESIST
    
    M. Spannagl e L. Frey, "New antiplatelet drugs", ANAESTHESIS, 50(3), 2001, pp. 142-149
40. Berger, PB; Dzavik, V; Penn, IM; Catellier, D; Buller, CE
    Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA)
    AMERICAN HEART JOURNAL
    
    P.B. Berger et al., "Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA)", AM HEART J, 142(5), 2001, pp. 776-781
41. Dillon, WC; Eckert, GJ; Dillon, JC; Ritchie, ME
    Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    W.C. Dillon et al., "Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine", CATHET C IN, 50(4), 2000, pp. 426-430
42. Kolansky, DM; Klugherz, BD; Curran, SC; Herrmann, HC; Magness, K; Wilensky, RL; Hirshfeld, JW
    Combination therapy with clopidogrel and aspirin after coronary stenting
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    D.M. Kolansky et al., "Combination therapy with clopidogrel and aspirin after coronary stenting", CATHET C IN, 50(3), 2000, pp. 276-279
43. Rupprecht, HJ
    Adenosine diphosphate receptor antagonists: from pharmacology to clinical practice
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    H.J. Rupprecht, "Adenosine diphosphate receptor antagonists: from pharmacology to clinical practice", EUR H J SUP, 2(E), 2000, pp. E1-E5
44. Liu, LS; Collins, R; Chen, ZM; Xie, JX; Jiang, LX; Wang, W; Pan, HC; Peto, R; Tao, SQ; Gong, LS; Hui, RT; Huang, TG; Zeng, DY; Chen, YZ; Liu, YH; Qian, TJ; Xu, CB; Dai, GZ; Feng, JZ; Cai, NS; Hu, DY; Huang, J; Li, TD; Li, YQ; Wang, LH; Yang, DC; Zhu, J; Zhu, DQ; Zhou, JC; Yang, XF; Cui, JJ; Jiang, BQ; Yin, JQ; San, J; Huang, DJ; Xi, WH; Fu, SY; Chen, YP; Gent, M
    Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction
    JOURNAL OF CARDIOVASCULAR RISK
    
    L.S. Liu et al., "Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction", J CARD RISK, 7(6), 2000, pp. 435-441
45. Elneairy, MAA; Eldin, SM; Attaby, FA; El-Louh, AKK
    Cyanothioacetamide in heterocyclic chemistry: Synthesis of thiopyran, pyridinethione, thienopyridine, pyridothienotriazine and pyridothienopyrimidinederivatives
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS
    
    M.A.A. Elneairy et al., "Cyanothioacetamide in heterocyclic chemistry: Synthesis of thiopyran, pyridinethione, thienopyridine, pyridothienotriazine and pyridothienopyrimidinederivatives", PHOSPHOR SU, 167, 2000, pp. 289-302
46. Bhatt, DL; Kapadia, SR; Yadav, JS; Topol, EJ
    Update on clinical trials of antiplatelet therapy for cerebrovascular diseases
    CEREBROVASCULAR DISEASES
    
    D.L. Bhatt et al., "Update on clinical trials of antiplatelet therapy for cerebrovascular diseases", CEREB DIS, 10, 2000, pp. 34-40
47. Weksler, BB
    Antiplatelet agents in stroke prevention - Combination therapy: Present and future
    CEREBROVASCULAR DISEASES
    
    B.B. Weksler, "Antiplatelet agents in stroke prevention - Combination therapy: Present and future", CEREB DIS, 10, 2000, pp. 41-48
48. Paciaroni, M; Gallai, V
    Antiplatelet agents for stroke prevention
    CEREBROVASCULAR DISEASES
    
    M. Paciaroni e V. Gallai, "Antiplatelet agents for stroke prevention", CEREB DIS, 10, 2000, pp. 36-39
49. Moore, SA; Steinhubl, SR
    Clopidogrel and coronary stenting: What is the next question?
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    S.A. Moore e S.R. Steinhubl, "Clopidogrel and coronary stenting: What is the next question?", J THROMB TH, 10(2), 2000, pp. 121-126
50. Kaufman, JS; Fiore, L; Hasbargen, JA; O'Connor, TZ; Perdriset, G
    A pharmacodynamic study of clopidogrel in chronic hemodialysis patients
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    J.S. Kaufman et al., "A pharmacodynamic study of clopidogrel in chronic hemodialysis patients", J THROMB TH, 10(2), 2000, pp. 127-131
51. Becker, RC
    Platelet surface physiology and its importance in pharmacotherapy design and development: The adenosine diphosphate receptor antagonists
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    R.C. Becker, "Platelet surface physiology and its importance in pharmacotherapy design and development: The adenosine diphosphate receptor antagonists", J THROMB TH, 10(1), 2000, pp. 35-53
52. Gryglewski, RJ; Dupin, JP; Uracz, W; Swies, J; Madej, J; Hou, G; Gravier, D; Casadebaig, F
    Thrombolysis by thienopyridines and their congeners
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    
    R.J. Gryglewski et al., "Thrombolysis by thienopyridines and their congeners", J PHYSL PH, 51(4), 2000, pp. 683-693
53. Burgos, A; Herbert, JM; Simpson, I
    ortho-metalation/chlorination of benzoic acid derivatives: Preparation of [benzene-U-C-13]-rac-Clopidogrel ([benzene-U-C-13]-rac-SR25990C).
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    
    A. Burgos et al., "ortho-metalation/chlorination of benzoic acid derivatives: Preparation of [benzene-U-C-13]-rac-Clopidogrel ([benzene-U-C-13]-rac-SR25990C).", J LABEL C R, 43(9), 2000, pp. 891-898
54. Savi, P; Pereillo, JM; Uzabiaga, MF; Combalbert, J; Picard, C; Maffrand, JP; Pascal, M; Herbert, JM
    Identification and biological activity of the active metabolite of clopidogrel
    THROMBOSIS AND HAEMOSTASIS
    
    P. Savi et al., "Identification and biological activity of the active metabolite of clopidogrel", THROMB HAEM, 84(5), 2000, pp. 891-896
55. Baurand, A; Eckly, A; Bari, N; Leon, C; Hechler, B; Cazenave, JP; Gachet, C
    Desensitization of the platelet aggregation response to ADP: Differential down-regulation of the P2Y(1) and P2cyc receptors
    THROMBOSIS AND HAEMOSTASIS
    
    A. Baurand et al., "Desensitization of the platelet aggregation response to ADP: Differential down-regulation of the P2Y(1) and P2cyc receptors", THROMB HAEM, 84(3), 2000, pp. 484-491
56. Wittke, B; Ensor, H; Chung, J; Birnbock, H; Lausecker, B; Ertel, SI; Mackie, IJ; Machin, SJ
    Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    B. Wittke et al., "Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin", BR J CL PH, 49(3), 2000, pp. 231-239
57. Alter, P; Schaefer, JR; Maisch, B
    Impediment of the cellular immune response under treatment with ticlopidine in aortic valve endocarditis caused by Staphylococcus aureus
    ZEITSCHRIFT FUR KARDIOLOGIE
    
    P. Alter et al., "Impediment of the cellular immune response under treatment with ticlopidine in aortic valve endocarditis caused by Staphylococcus aureus", Z KARDIOL, 89(8), 2000, pp. 691
58. Takahashi, O
    Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis
    FOOD AND CHEMICAL TOXICOLOGY
    
    O. Takahashi, "Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis", FOOD CHEM T, 38(2-3), 2000, pp. 203-218
59. De Feyter, PJ; Foley, D
    Coronary stent implantation: a panacea for the interventional cardiologist?
    EUROPEAN HEART JOURNAL
    
    P.J. De Feyter e D. Foley, "Coronary stent implantation: a panacea for the interventional cardiologist?", EUR HEART J, 21(21), 2000, pp. 1719-1726
60. Phatouros, CC; Lefler, JE; Higashida, RT; Meyers, PM; Malek, AM; Dowd, CF; Halbach, VV
    Primary stenting for high-grade basilar artery stenosis
    AMERICAN JOURNAL OF NEURORADIOLOGY
    
    C.C. Phatouros et al., "Primary stenting for high-grade basilar artery stenosis", AM J NEUROR, 21(9), 2000, pp. 1744-1749
61. Tong, FC; Cloft, HJ; Joseph, GJ; Samuels, OB; Dion, JE
    Abciximab rescue in acute carotid stent thrombosis
    AMERICAN JOURNAL OF NEURORADIOLOGY
    
    F.C. Tong et al., "Abciximab rescue in acute carotid stent thrombosis", AM J NEUROR, 21(9), 2000, pp. 1750-1752
62. King, SB
    Optimizing antiplatelet therapy in coronary interventions
    CLINICAL CARDIOLOGY
    
    S.B. King, "Optimizing antiplatelet therapy in coronary interventions", CLIN CARD, 23(11), 2000, pp. 8-13
63. Montalescot, G
    Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease
    CLINICAL CARDIOLOGY
    
    G. Montalescot, "Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease", CLIN CARD, 23(11), 2000, pp. 18-22
64. Topol, EJ
    The future of antiplatelet therapy: Optimizing management in patients withacute coronary syndrome
    CLINICAL CARDIOLOGY
    
    E.J. Topol, "The future of antiplatelet therapy: Optimizing management in patients withacute coronary syndrome", CLIN CARD, 23(11), 2000, pp. 23-28
65. Qureshi, AI; Luft, AR; Sharma, M; Guterman, LR; Hopkins, LN
    Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I - Pathophysiological and pharmacological features
    NEUROSURGERY
    
    A.I. Qureshi et al., "Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I - Pathophysiological and pharmacological features", NEUROSURGER, 46(6), 2000, pp. 1344-1359
66. Goette, A; Ittenson, A; Hoffmanns, P; Reek, S; Hartung, W; Klein, H; Ansorge, S; Geller, JC
    Increased expression of P-selectin in patients with chronic atrial fibrillation
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    
    A. Goette et al., "Increased expression of P-selectin in patients with chronic atrial fibrillation", PACE, 23(11), 2000, pp. 1872-1875
67. Reist, M; Roy-De Vos, M; Montseny, JP; Mayer, JM; Carrupt, PA; Berger, Y; Testa, B
    Very slow chiral inversion of clopidogrel in rats: A pharmacokinetic and mechanistic investigation
    DRUG METABOLISM AND DISPOSITION
    
    M. Reist et al., "Very slow chiral inversion of clopidogrel in rats: A pharmacokinetic and mechanistic investigation", DRUG META D, 28(12), 2000, pp. 1405-1410
68. Giardino, EC; Costanzo, MJ; Kauffman, JA; Li, QS; Maryanoff, BE; Andrade-Gordon, P
    Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor
    THROMBOSIS RESEARCH
    
    E.C. Giardino et al., "Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor", THROMB RES, 98(1), 2000, pp. 83-93
69. Fork, FT; Lafolie, P; Toth, E; Lindgarde, F
    Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers - A gastroscopic study
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    F.T. Fork et al., "Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers - A gastroscopic study", SC J GASTR, 35(5), 2000, pp. 464-469
70. Link, J; Manke, C; Rosin, L; Borisch, I; Topel, I; Horn, M; Mann, S; Jauch, KW; Bogdahn, U; Feuerbach, S; Kasprzak, P
    Carotid endarteriectomy and carotic stenting. Pilot study of a prospective, randomized and controlled comparison
    RADIOLOGE
    
    J. Link et al., "Carotid endarteriectomy and carotic stenting. Pilot study of a prospective, randomized and controlled comparison", RADIOLOGE, 40(9), 2000, pp. 813-820
71. Nickolaus, MJ; Chambers, CE; Ettinger, SM; Gilchrist, IC; Kozak, M
    Advances in interventional cardiology - Beyond the balloon
    NURSING CLINICS OF NORTH AMERICA
    
    M.J. Nickolaus et al., "Advances in interventional cardiology - Beyond the balloon", NURS CLIN N, 35(4), 2000, pp. 897
72. Slavina, NN; Averkov, OV; Gratsiansky, NA
    Unstable angina. Short term treatment with clopidogrel with the use of a loading dose: Effect on ADP-induced platelet aggregation
    KARDIOLOGIYA
    
    N.N. Slavina et al., "Unstable angina. Short term treatment with clopidogrel with the use of a loading dose: Effect on ADP-induced platelet aggregation", KARDIOLOGIY, 40(12), 2000, pp. 30-37
73. Takamatsu, H; Tsukada, H; Kakiuchi, T; Tatsumi, M; Umemura, K
    Changes in local cerebral blood flow in photochemically induced thromboticocclusion model in rats
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    H. Takamatsu et al., "Changes in local cerebral blood flow in photochemically induced thromboticocclusion model in rats", EUR J PHARM, 398(3), 2000, pp. 375-379
74. Jarvis, B; Simpson, K
    Clopidogrel - A review of its use in the prevention of atherothrombosis
    DRUGS
    
    B. Jarvis e K. Simpson, "Clopidogrel - A review of its use in the prevention of atherothrombosis", DRUGS, 60(2), 2000, pp. 347-377
75. Muller, C; Buttner, HJ; Petersen, J; Roskamm, H
    A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
    CIRCULATION
    
    C. Muller et al., "A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents", CIRCULATION, 101(6), 2000, pp. 590-593
76. Sugidachi, A; Asai, F; Ogawa, T; Inoue, T; Koike, H
    The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties
    BRITISH JOURNAL OF PHARMACOLOGY
    
    A. Sugidachi et al., "The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties", BR J PHARM, 129(7), 2000, pp. 1439-1446
77. Jarvis, GE; Humphries, RG; Robertson, MJ; Leff, P
    ADP can induce aggregation of human platelets via both P2Y(1) and P-2T receptors
    BRITISH JOURNAL OF PHARMACOLOGY
    
    G.E. Jarvis et al., "ADP can induce aggregation of human platelets via both P2Y(1) and P-2T receptors", BR J PHARM, 129(2), 2000, pp. 275-282
78. Steinhubl, SR
    Antiplatelet agents in cardiology: The choice of therapy
    ANNALS OF THORACIC SURGERY
    
    S.R. Steinhubl, "Antiplatelet agents in cardiology: The choice of therapy", ANN THORAC, 70(2), 2000, pp. S3-S8
79. Keser, C
    Antiplatelet agents in spinal anesthesia
    ANAESTHESIST
    
    C. Keser, "Antiplatelet agents in spinal anesthesia", ANAESTHESIS, 49(3), 2000, pp. 234-235
80. King, SP
    Interventions in cardiology: What does and does not work
    AMERICAN JOURNAL OF CARDIOLOGY
    
    S.P. King, "Interventions in cardiology: What does and does not work", AM J CARD, 86(4B), 2000, pp. 3H-5H
81. Nenci, GG
    Unifying concept of arterial vascular disease
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    G.G. Nenci, "Unifying concept of arterial vascular disease", EUR H J SUP, 1(A), 1999, pp. A27-A30
82. Herbert, JM; Savi, P; Maffrand, JP
    Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J.M. Herbert et al., "Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist", EUR H J SUP, 1(A), 1999, pp. A31-A40
83. Cattaneo, M; Gachet, C
    ADP receptors and clinical bleeding disorders
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M. Cattaneo e C. Gachet, "ADP receptors and clinical bleeding disorders", ART THROM V, 19(10), 1999, pp. 2281-2285
84. Zeolla, MM; Carson, JJ
    Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity
    ANNALS OF PHARMACOTHERAPY
    
    M.M. Zeolla e J.J. Carson, "Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity", ANN PHARMAC, 33(9), 1999, pp. 939-941
85. Gurbel, PA; O'Connor, CM; Cummings, CC; Serebruany, VL
    Clopidogrel: The future choice for preventing platelet activation during coronary stenting?
    PHARMACOLOGICAL RESEARCH
    
    P.A. Gurbel et al., "Clopidogrel: The future choice for preventing platelet activation during coronary stenting?", PHARMAC RES, 40(2), 1999, pp. 107-111
86. Hagberg, IA; Solvik, UO; Opdahl, H; Roald, HE; Lyberg, T
    Inhalation of nitric oxide inhibits ADP-induced platelet aggregation and alpha-granule release
    PLATELETS
    
    I.A. Hagberg et al., "Inhalation of nitric oxide inhibits ADP-induced platelet aggregation and alpha-granule release", PLATELETS, 10(6), 1999, pp. 382-390
87. Ziemianin, B; Olszanecki, R; Uracz, W; Marcinkiewicz, E; Gryglewski, RJ
    Thienopyridines: Effects on cultured endothelial cells
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    
    B. Ziemianin et al., "Thienopyridines: Effects on cultured endothelial cells", J PHYSL PH, 50(4), 1999, pp. 597-604
88. David, JL; Limet, R
    Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients
    THROMBOSIS AND HAEMOSTASIS
    
    J.L. David e R. Limet, "Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients", THROMB HAEM, 82(5), 1999, pp. 1417-1421
89. Leon, C; Vial, C; Gachet, C; Ohlmann, P; Hechler, B; Cazenave, JP; Lecchi, A; Cattaneo, M
    The P2Y(1) receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation - Further evidence for a distinct P2 receptor responsible for adenylyl cyclase inhibition
    THROMBOSIS AND HAEMOSTASIS
    
    C. Leon et al., "The P2Y(1) receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation - Further evidence for a distinct P2 receptor responsible for adenylyl cyclase inhibition", THROMB HAEM, 81(5), 1999, pp. 775-781
90. Taka, T; Okano, E; Seki, J; Yamamoto, J
    Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress
    HAEMOSTASIS
    
    T. Taka et al., "Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress", HAEMOSTASIS, 29(4), 1999, pp. 189-196
91. Nenci, GG
    Unifying concept of arterial vascular disease
    EUROPEAN HEART JOURNAL
    
    G.G. Nenci, "Unifying concept of arterial vascular disease", EUR HEART J, 20, 1999, pp. A27-A30
92. Herbert, JM; Savi, P; Maffrand, JP
    Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist
    EUROPEAN HEART JOURNAL
    
    J.M. Herbert et al., "Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist", EUR HEART J, 20, 1999, pp. A31-A40
93. Wilson, JM; Ferguson, JJ
    Platelet-endothelial interactions in atherothrombotic disease: Therapeuticimplications
    CLINICAL CARDIOLOGY
    
    J.M. Wilson e J.J. Ferguson, "Platelet-endothelial interactions in atherothrombotic disease: Therapeuticimplications", CLIN CARD, 22(11), 1999, pp. 687-698
94. Bernat, A; Hoffmann, P; Savi, P; Lale, A; Herbert, JM
    Interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic effects of SR 121566A, a novel nonpeptide GP IIb IIIa antagonist
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    A. Bernat et al., "Interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic effects of SR 121566A, a novel nonpeptide GP IIb IIIa antagonist", J CARDIO PH, 33(6), 1999, pp. 897-904
95. Savcic, M; Hauert, J; Bachmann, F; Wyld, PJ; Geudelin, B; Cariou, R
    Clopidogrel loading dose regimens: Kinetic profile of pharmacodynamic response in healthy subjects
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    M. Savcic et al., "Clopidogrel loading dose regimens: Kinetic profile of pharmacodynamic response in healthy subjects", SEM THROMB, 25, 1999, pp. 15-19
96. Caplain, H; Cariou, R
    Long-term activity of clopidogrel: A three-month appraisal in healthy volunteers
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    H. Caplain e R. Cariou, "Long-term activity of clopidogrel: A three-month appraisal in healthy volunteers", SEM THROMB, 25, 1999, pp. 21-23
97. Caplain, H; Donat, F; Gaud, C; Necciari, J
    Pharmacokinetics of clopidogrel
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    H. Caplain et al., "Pharmacokinetics of clopidogrel", SEM THROMB, 25, 1999, pp. 25-28
98. Lins, R; Broekhuysen, J; Necciari, J; Deroubaix, X
    Pharmacokinetic profile of C-14-labeled clopidogrel
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    R. Lins et al., "Pharmacokinetic profile of C-14-labeled clopidogrel", SEM THROMB, 25, 1999, pp. 29-33
99. Pierce, CH; Houle, JM; Dickinson, JP; Kindermans, M; Serre-Lacroix, E; Kieffer, G; Necciari, J
    Clopidogrel and drug metabolism: Absence of effect on hepatic enzymes in healthy volunteers
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    C.H. Pierce et al., "Clopidogrel and drug metabolism: Absence of effect on hepatic enzymes in healthy volunteers", SEM THROMB, 25, 1999, pp. 35-39
100. McEwen, J; Strauch, G; Perles, P; Pritchard, G; Moreland, TE; Necciari, J; Dickinson, JP
     Clopidogrel bioavailability: Absence of influence of food or antacids
     SEMINARS IN THROMBOSIS AND HEMOSTASIS
     
     J. McEwen et al., "Clopidogrel bioavailability: Absence of influence of food or antacids", SEM THROMB, 25, 1999, pp. 47-50